Hydroxytyrosol as a Mitochondrial Homeostasis Regulator: Implications in Metabolic Syndrome and Related Diseases
Antioxidants · 27.03.2025 · 14 (4) · 398
DOI: 10.3390/antiox14040398 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 27.03.2025. Verfasst von Jie Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Mitochondrial Biology and Medicine, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Scie…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Youth Talent Support Program of Shaanxi Association for Science and Technology, the Natural Science Foundation of Sichuan Province, the Shandong Provincial Natural Foundation.
Abstract (Originalsprache)
Hydroxytyrosol (HT), a principal bioactive phytochemical abundant in Mediterranean dietary sources, has emerged as a molecule of significant scientific interest owing to its multifaceted health-promoting properties. Accumulating evidence suggests that HT’s therapeutic potential in metabolic disorders extends beyond conventional antioxidant capacity to encompass mitochondrial regulatory networks. This review synthesizes contemporary evidence from our systematic investigations and the existing literature to delineate HT’s comprehensive modulatory effects on mitochondrial homeostasis. We systematically summarized the impact of HT on mitochondrial dynamics (fusion/fission equilibrium), biogenesis and energy metabolism, mitophagy, inter-organellar communication with the endoplasmic reticulum, and microbiota–mitochondria crosstalk. Through this multidimensional analysis, we established HT as a mitochondrial homeostasis modulator with potential therapeutic applications in metabolic syndrome (MetS) and its related pathologies including type 2 diabetes mellitus, obesity-related metabolic dysfunction, dyslipidemia, non-alcoholic steatohepatitis, and hypertension-related complications. Moreover, we further discussed translational challenges in HT research, emphasizing the imperative for direct target identification, mitochondrial-targeted delivery system development, and combinatorial therapeutic strategies. Collectively, this review provides a mechanistic framework for advancing HT research and accelerating its clinical implementation in MetS and its related diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Mitochondrial Biology and Medicine, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
- School of Health and Life Sciences, University of Health and Rehabilitation Sciences, Qingdao 266071, China.
- Frontier Institute of Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China.
ORCID-Profile: Jiangang Long, Jiankang Liu, Ke Cao
Förderung
- the Youth Talent Support Program of Shaanxi Association for Science and Technology
- the Natural Science Foundation of Sichuan Province
- the Shandong Provincial Natural Foundation
- the Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- National Natural Science Foundations of China
- Youth Talent Support Program of Shaanxi Association for Science and Technology
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Xu, J., Wei, H., Sun, Z., Li, W., Long, J., Liu, J., Feng, Z., & Cao, K. (2025). Hydroxytyrosol as a Mitochondrial Homeostasis Regulator: Implications in Metabolic Syndrome and Related Diseases. Antioxidants, 14(4), 398. https://doi.org/10.3390/antiox14040398
Vancouver
Xu J, Wei H, Sun Z, Li W, Long J, Liu J, et al. Hydroxytyrosol as a Mitochondrial Homeostasis Regulator: Implications in Metabolic Syndrome and Related Diseases. Antioxidants. 2025;14(4):398. doi:10.3390/antiox14040398
BibTeX
@article{Xu2025,
author = {Xu, Jie and Wei, Huanglong and Sun, Zhenyu and Li, Wankang and Long, Jiangang and Liu, Jiankang and Feng, Zhihui and Cao, Ke},
title = {Hydroxytyrosol as a Mitochondrial Homeostasis Regulator: Implications in Metabolic Syndrome and Related Diseases},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {4},
pages = {398},
doi = {10.3390/antiox14040398}
}
EUVIMED